The Roboticist Chronicles: Robots Aren’t Stealing Your Jobs, They’re Creating Them

 

As technology advances at an exponential rate, a common fearful sentiment among Americans is that robots are stealing human jobs. But, this long standing rumor couldn’t be farther from the truth. Robots actually create jobs, save humans from harm, and open up opportunities for new industry growth. The Roboticist Chronicles unpacks how robots are helping humans and changing industries of all kinds in this episode with guest Dan Allford, President and Founder of ARC Specialties.

“Robots aren’t bad, bad integrators are bad,” Allford said, explaining how robots have gotten a bad rap in the past having been improperly assigned to ill-fitting jobs and tasks.

But robots have also found great success when assigned to tasks where they shine, like washing dishes or clothing, or crafting contact lenses. As a result, the life of humanity has changed for the better.

“There’s still a place in the world for people,” he said.

The robot is perhaps best glorified in their role of saving humans from harmful, dangerous tasks. Robots have replaced jobs where humans would have been exposed to extreme temperatures, dangerous chemicals, or harmful gases.

And robots are on the brink of another stage of evolution with the “collaborative robot,” that is, a robot that works side by side with humans.

“There are some things that people do better, and some things that robots do better,” Allford said. And when a symbiotic relationship is struck between the two parties, robotics don’t dampen human capabilities, they uplift them.

Be it medicine, oil drilling, aeronautics, plumbing, or space exploration, robotics have helped push industry forward by taking on tasks better suited for automation and precision. Robotics expert, Dan Allford, elaborates on why correctly identifying jobs where robots excel is the key to mechanization helping humanity move forward.

For the latest news, videos, and podcasts in the Engineering & Construction Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More